Search

everythinglearnresearchcommunity

for

Search:↓

Young and adult hamsters both respond similarly to testosterone and finasteride treatments, but young hamsters aren't good for testing the inhibitory activity of a specific enzyme.

Androgen deprivation therapy might be better for preventing COVID-19 than treating it.

Dutasteride reduces DHT more effectively than finasteride.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Combination therapy for BPH is cost-effective, especially for men with larger prostates.

Finasteride, a hair loss drug, may cause sexual dysfunction and depression, but these effects are usually temporary and the drug is generally safe. More research is needed.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Finasteride can cause sexual dysfunction, sperm changes, and affect bone density and metabolism.

D-004 may be a natural alternative to finasteride for treating enlarged prostate and male baldness.

Dosing time affects finasteride's effectiveness and safety in rats.

Omega-6 fats in certain cells boost male hormone production.

Analog 23 is a promising compound for prostate cancer treatment.

Men with certain types of baldness at age 45 may have a higher risk of colon cancer and colorectal adenoma.

Dutasteride is more effective than finasteride in reducing urinary retention and surgery risks in people aged 65 and older.

Caesalpinia bonduc seed extracts may help treat enlarged prostate in rats.

Testosterone replacement therapy improved blood sugar and fat levels without raising prostate cancer risk in Japanese men with low testosterone.

Balding and low testosterone increase risk of urinary stones.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Case-only trees and random forests improve predictions of treatment effects in clinical trials.

Accurate protein modeling can help develop new treatments for prostate cancer and other diseases.

Finasteride significantly reduces fertility in male rats.

Tripterygium wilfordii multiglycoside effectively reduced prostate enlargement in rats without harmful effects.

Early hair loss may indicate future prostate issues.

Higher urethral PSA levels after prostate removal may be linked to more scalp hair loss and more PSA in urethral glands.

Dihydrotestosterone (DHT) mainly affects nearby cells, doesn't significantly change prostate hormonal environment or cancer risk, and doesn't play a main role in causing hair loss or acne. More research is needed on its effects on heart health, sexual function, and bone health.

Prostate cancer patients need early psychological and sexual support during radiotherapy to improve their quality of life.

Higher free testosterone levels can increase bone density and decrease body fat but may raise the risk of prostate cancer, hair loss, and benign prostate enlargement.